Clinical trial
A Prostate Cancer Study in Men Undergoing Androgen Deprivation Therapy
NCT00087659 · Novartis Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00087659 |
|---|---|
| Title | A Prostate Cancer Study in Men Undergoing Androgen Deprivation Therapy |
| Lead sponsor | Novartis Pharmaceuticals, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Drug |
| Interventions | zoledronic acid |
| Start date | Dec 1, 2003 |
| Completion | May 1, 2007 |
| First posted | Jul 14, 2004 |
| Last update posted | Nov 23, 2009 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: